عيادة لاستعادة الشعر بإشراف جراح في ليفنت، إسطنبول، منذ 2007.
استعرض الكل ←أرسل 3–5 صور. رد شخصي خلال 24 ساعة — بدون وسطاء.
اطلب الآن ←FUE, DHI or Algorithmic FUE™ — Dr. Arslan recommends based on your photographs and Norwood stage.
احصل على تقييم ← جرّب الحاسبة ←عضو FUE Europe. عيادة معتمدة من وزارة الصحة. ليفنت، إسطنبول — أقل بنسبة 60–80% من بريطانيا أو الولايات المتحدة.
اطّلع على الباقة ←عضو FUE Europe. معتمد من وزارة الصحة. أكثر من 17 عاماً. أكثر من 4500 عملية أجراها بنفسه. مريض واحد في اليوم.
الملف الكامل ←كل طعم يُزرع بيده. وكل نتيجة مسؤوليته الشخصية.
اقرأ الفلسفة ←لا تكاليف خفية. الفندق والمواصلات والعملية والمتابعة في سعر واحد.
اطّلع على الأسعار ←Silver · Gold · VIP — فندق 5 نجوم · مواصلات المطار · PRP مشمول
اطّلع على الأسعار ← حاسبة الطعوم ←ليست كل حالة تحتاج زراعة. علاجات دوائية وعلاجات أخرى وخيارات تخصصية.
نظرة عامة ←Phase 1 — Trauma response (Days 0–14): Follicles experience extraction and implantation trauma. Inflammatory response. Scab formation. Most follicles enter telogen.
Phase 2 — Telogen dormancy (Weeks 2–Month 3): Shock loss. Follicles resting. No visible growth. The appearance is worse than surgery day — this is normal and expected.
Phase 3 — Anagen entry (Months 3–7): Follicles re-enter active growth. Fine hairs emerge. Density building progressively week by week.
Phase 4 — Maturation (Months 7–14): Hair calibre increases. Full texture develops. Integration with native hair. Final permanent result achieved.

| Timeline | Clinical status | Patient experience |
|---|---|---|
| Day 1–3 | Graft integration begins | Mild pain, scabs, forehead swelling |
| Day 4–10 | Scabs hardening. Grafts anchoring. | Reduced pain. Redness reducing. |
| Week 2–5 | Shock loss phase | Hair shedding — alarming but normal |
| Month 2 | Full telogen dormancy | No change visible — worst month psychologically |
| Month 3 | Anagen begins in first follicles | Fine hairs in bright light |
| Month 5 | ~50% density | Clear improvement visible to others |
| Month 7 | ~75% density | Most patients comfortable socially |
| Month 10 | ~90% density | Result essentially final |
| Month 12–14 | Full maturation | Permanent, natural, integrated result |
Individual variation in growth timeline is driven by: age (younger patients often enter anagen slightly sooner), general health, nutritional status (iron, ferritin, vitamin D deficiency slows recovery), hair calibre, and surgical extent. None of these variations indicate failure — they shift the timeline by 2–6 weeks without affecting the final result quality.

Yes. AI is used for trichoscopy donor density mapping, graft count estimation from photographs, and digital hairline design simulation. At Hairmedico, AI-assisted trichoscopy is part of the Algorithmic FUE planning process. Robotic extraction is not used — Dr. Arslan's manual FUE achieves lower transection rates across all hair types.
AI simulation tools can show proposed hairline positions on photographs, but cannot predict actual graft survival (depends on surgeon quality), actual density (depends on hair calibre), or how the result interacts with future native hair loss. They are design communication aids, not result guarantees.
Not in the foreseeable future. AI adds value in data analysis (density mapping, graft counting) but cannot replace the aesthetic judgment required for natural hairline design, the technical adaptation required for diverse hair types, or the long-term clinical planning that accounts for individual hair loss trajectories.
Hairmedico all-inclusive: EUR 1,990–2,900 for 2,000–3,500 grafts including surgery, 5-star hotel, transfers, PRP and 12-month follow-up.
Yes. Transplanted follicles are DHT-resistant and grow permanently for the patient's lifetime.
Desk work: 5–7 days. Scabs shed by Day 10–14. New growth from months 3–5. Final result months 12–14.
Dr. Arslan Musbeh personally — every extraction, every channel, every graft. One patient per day.
Yes, with an accredited surgeon-led clinic. Verify FUE Europe membership, Ministry of Health registration, and confirm the surgeon personally operates.
All references are peer-reviewed medical literature or official health authority publications. No commercial sources included.